Molecular Inflammation Board at the Center for Personalized Medicine

Molecular Inflammation Board at the Center for Personalized Medicine

The study objectives are:

To ensure a prospective documentation of all patients who are referred to the Molecular Inflammation Board in routine clinical care To prospectively ensure the documentation of MEB patients with an emphasis to clinical outcome parameters and further response assessments (e.g. peripheral immunmonitoring, imaging parameters) To prospectively assess patient-reported outcome of MEB patients To evaluate compliance to MEB suggestions in routine clinical care

Inclusion Criteria:

• Chronic inflammatory disorder (PsO, PsA, SpA, IBD)
• Given informed consent
• 18 years of age

Exclusion Criteria:

• No capacity to consent

Patients with chronic inflammatory diseases and indication for therapy with biologic agents